The Cooper Companies, Inc. (COO)
The Cooper Companies, Inc. (COO) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $61.31, down 0.92% on the day, which values the company at $11.66B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.
Key facts
- Share price
- $61.31−0.92% today
- Market value
- $11.66B
- P/E ratio
- 21.1×last 12 months
- Forward P/E
- 13.1×
- Funk Score
- 61/100
- Against its own history
- Well below its usual priceusual price $89.04
- 200-week average
- $83.7427% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
The Cooper Companies, Inc. in more detail
COO trades at 21.1× its last twelve months' earnings, 13.1× next year's expected earnings, 2.8× sales. Measured against its own history, the price is 31% below what its usual multiples would imply ($89.04) — well below its usual price. It sits 27% below its 200-week average of $83.74.
Over the last five fiscal years The Cooper Companies, Inc. has compounded revenue 11.0% a year, earnings per share 9.2% a year, free cash flow 19.7% a year. Its Funk Score is 61 out of 100 (financial strength 4.7, profitability 5.2, growth 6.9, value 7.6, each out of 10).
In its favour: Altman Z in the safe zone; Five straight years of revenue growth. Worth checking: Low return on invested capital.
7 of the superinvestors tracked here hold COO, including Barry Rosenstein (13.7% of the portfolio), Glenn Greenberg (4.9% of the portfolio), Mark Boyar (1.2% of the portfolio).
Superinvestors holding COO
7 of the investors tracked here report a position in their latest 13F filing.
- Barry Rosenstein Jana Partners13.7% of portfolio · $217M · added · Q3 2026
- Glenn Greenberg Brave Warrior Advisors4.94% of portfolio · $213.5M · new · Q3 2026
- Mark Boyar Boyar Asset Management1.17% of portfolio · $1.9M · added · Q3 2026
- Diamond Hill team Diamond Hill Capital Management0.43% of portfolio · $39.8M · trimmed · Q3 2026
- Brandon Haley Holocene Advisors0.18% of portfolio · $77.5M · new · Q2 2026
- Ken Griffin Citadel Advisors0.16% of portfolio · $277.7M · added · Q2 2026
- Bill Nygren Harris Associates (Oakmark)0.07% of portfolio · $55M · new · Q2 2026
Health Care companies of similar size
- Elanco Animal HealthELAN
- Smith & NephewSNN
- PenumbraPEN
- Dr. Reddy's LaboratoriesRDY
- Align TechnologyALGN
- Fresenius Medical CareFMS
- Kymera TherapeuticsKYMR
- DaVitaDVA
- Halozyme TherapeuticsHALO
- Universal Health ServicesUHS
- RepligenRGEN
- Bio-TechneTECH
Side by side:COO vs ALGN (The Cooper Companies, Inc. vs Align Technology)COO vs RDY (The Cooper Companies, Inc. vs Dr. Reddy's Laboratories)COO vs PEN (The Cooper Companies, Inc. vs Penumbra)COO vs FMS (The Cooper Companies, Inc. vs Fresenius Medical Care)COO vs SNN (The Cooper Companies, Inc. vs Smith & Nephew)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
The Cooper Companies, Inc. (COO): questions and answers
What is COO's P/E ratio?
The Cooper Companies, Inc. trades at 21.1× its last twelve months' earnings and 13.1× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 7.0× to 91.9×, with a median of 31.3×.
What is COO's PEG ratio?
The Cooper Companies, Inc.'s PEG ratio is 0.59 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is The Cooper Companies, Inc.'s market cap?
The Cooper Companies, Inc. is valued at $11.66B at a share price of $61.31.
Is COO overvalued or undervalued?
Against its own history, COO is well below its usual price: the price is 31% below the $89.04 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is COO above its 200-week moving average?
No. COO is 26.8% below its 200-week average of $83.74. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is The Cooper Companies, Inc. growing?
Over the last five fiscal years The Cooper Companies, Inc.'s revenue grew 11.0% a year and its earnings per share 9.2% a year; over ten years revenue grew 8.6% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “The Cooper Companies, Inc. (COO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COO
Underlying data: Yahoo Finance; company filings with the SEC.